{"url_path":"/sec/mbot/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/883975/0001493152-26-022792-index.html","accession_number":"0001493152-26-022792","cik":"0000883975","ticker":"MBOT","issuer_name":"Microbot Medical Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/883975/0001493152-26-022792-index.html","primary_entity_key":"0000883975","primary_entity_name":"Microbot Medical Inc."},"word_count":1026,"has_tables":true,"body_markdown":"**Item\n6. Exhibits**\n\n \n\n2.1\n\n[Agreement and Plan of Merger and Reorganization, dated as of August 15, 2016, by and among StemCells, Inc., C&RD Israel Ltd. and Microbot Medical Ltd. (incorporated by reference to the Company’s Current Report on Form 8-K filed on August 15, 2016).](https://www.sec.gov/Archives/edgar/data/883975/000119312516682077/d161430dex21.htm)\n\n3.1\n\n[Restated Certificate of Incorporation of the Company (incorporated by reference to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006 and filed on March 15, 2007).](https://www.sec.gov/Archives/edgar/data/883975/000095013407005808/f27726exv3w1.htm)\n\n3.2\n\n[Certificate of Amendment to the Restated Certificate of Incorporation of the Company (incorporated by reference to the Company’s Current Report on Form 8-K filed on November 29, 2016).](https://www.sec.gov/Archives/edgar/data/883975/000119312516779597/d296933dex31.htm)\n\n3.3\n\n[Certificate of Amendment to the Restated Certificate of Incorporation (incorporated by reference to the Company’s Current Report on Form 8-K filed on September 4, 2018).](https://www.sec.gov/Archives/edgar/data/883975/000149315218012872/ex3-1.htm)\n\n3.4\n\n[Amended and Restated By-Laws of the Company (incorporated by reference to the Company’s Current Report on Form 8-K filed on May 3, 2016).](https://www.sec.gov/Archives/edgar/data/883975/000129993316002374/exhibit1.htm)\n\n3.5\n\n[Certificate of Elimination (incorporated by reference to the Company’s Current Report on Form 8-K filed on December 12, 2018).](https://www.sec.gov/Archives/edgar/data/883975/000149315218017395/ex3-1.htm)\n\n3.6\n\n[Certificate of Amendment to the Restated Certificate of Incorporation (incorporated by reference to the Company’s Current Report on Form 8-K filed on September 11, 2019).](https://www.sec.gov/Archives/edgar/data/883975/000149315219013998/ex3-1.htm)\n\n \n\n27\n\n \n\n \n\n3.7\n\n[Amendment to Section 5 of the Amended and Restated By-Laws of the Company (incorporated by reference to the Company’s Current Report on Form 8-K filed on May 3, 2021).](https://www.sec.gov/Archives/edgar/data/883975/000149315221010347/ex3-1.htm)\n\n3.8\n[Amendment to Section 2.5 of the Amended and Restated By-Laws (incorporated by reference to the Company’s Current Report on Form 8-K filed on April 14, 2025).](https://www.sec.gov/Archives/edgar/data/883975/000164117225004707/ex3-1.htm)\n\n4.1\n[Description of the Company’s Securities (incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025).](https://www.sec.gov/Archives/edgar/data/883975/000164117225023206/ex4-1.htm)\n\n4.2\n\n[Form of Series A Warrant (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on October 25, 2022)](https://www.sec.gov/Archives/edgar/data/883975/000149315222029541/ex4-2.htm)\n\n4.3\n\n[Form of Wainwright Warrant (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on October 25, 2022)](https://www.sec.gov/Archives/edgar/data/883975/000149315222029541/ex4-4.htm)\n\n4.4\n\n[Form of Wainwright Warrant (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on May 23, 2023)](https://www.sec.gov/Archives/edgar/data/883975/000149315223018718/ex4-1.htm)\n\n4.5\n\n[Form of Wainwright Warrant (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on May 24, 2023)](https://www.sec.gov/Archives/edgar/data/883975/000149315223018932/ex4-2.htm)\n\n4.6\n\n[Form of Warrant Amendment Agreement (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on May 24, 2023)](https://www.sec.gov/Archives/edgar/data/883975/000149315223018932/ex10-2.htm)\n\n4.7\n\n[Form of Series C Warrant (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on June 6, 2023)](https://www.sec.gov/Archives/edgar/data/883975/000149315223020309/ex4-1.htm)\n\n4.8\n\n[Form of Wainwright Warrant (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on June 6, 2023)](https://www.sec.gov/Archives/edgar/data/883975/000149315223020309/ex4-2.htm)\n\n4.9\n[Form of Series D Warrant (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on June 28, 2023)](https://www.sec.gov/Archives/edgar/data/883975/000149315223022814/ex4-1.htm)\n\n4.10\n[Form of Wainwright Warrant (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on June 28, 2023)](https://www.sec.gov/Archives/edgar/data/883975/000149315223022814/ex4-2.htm)\n\n4.11\n[Form of Inducement Investment Option (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on January 2, 2024)](https://www.sec.gov/Archives/edgar/data/883975/000149315224000109/ex4-1.htm)\n\n4.12\n[Form of Placement Agent Investment Option (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on January 2, 2024)](https://www.sec.gov/Archives/edgar/data/883975/000149315224000109/ex4-2.htm)\n\n4.13\n[Form of Series F Preferred Investment Option (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on June 4, 2024)](https://www.sec.gov/Archives/edgar/data/883975/000149315224022560/ex4-1.htm)\n\n4.14\n[Form of Placement Agent Investment Option (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on June 4, 2024)](https://www.sec.gov/Archives/edgar/data/883975/000149315224022560/ex4-2.htm)\n\n4.15\n[Form of Series G Preferred Investment Option (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on January 7, 2025)](https://www.sec.gov/Archives/edgar/data/883975/000149315225001133/ex4-1.htm)\n\n4.16\n[Form of Placement Agent Investment Option (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on January 7, 2025)](https://www.sec.gov/Archives/edgar/data/883975/000149315225001133/ex4-2.htm)\n\n4.17\n[Form of Series H Preferred Investment Option (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on January 10, 2025)](https://www.sec.gov/Archives/edgar/data/883975/000149315225001559/ex4-1.htm)\n\n4.18\n[Form of Placement Agent Investment Option (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on January 10, 2025)](https://www.sec.gov/Archives/edgar/data/883975/000149315225001559/ex4-2.htm)\n\n4.19\n[Form of Series I Preferred Investment Option (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on February 11, 2025)](https://www.sec.gov/Archives/edgar/data/883975/000149315225005820/ex4-1.htm)\n\n4.20\n[Form of Placement Agent Investment Option (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on February 11, 2025)](https://www.sec.gov/Archives/edgar/data/883975/000149315225005820/ex4-2.htm)\n\n10.1\n[Addendum #3 to Employment Agreement, dated as of February 20, 2026, with Simon Sharon (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on February 24, 2026)](https://www.sec.gov/Archives/edgar/data/883975/000149315226007900/ex10-1.htm)\n\n10.2\n[Addendum #3 to Employment Agreement, dated as of February 20, 2026, with Rachel Vaknin (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on February 24, 2026)](https://www.sec.gov/Archives/edgar/data/883975/000149315226007900/ex10-2.htm)\n\n10.3\n[Amendment #2 to Employment Agreement, dated as of February 20, 2026, with Juan Diaz-Cartelle (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on February 24, 2026)](https://www.sec.gov/Archives/edgar/data/883975/000149315226007900/ex10-3.htm)\n\n31.1\n[Certification of Harel Gadot, Chairman, President and Chief Executive Officer](ex31-1.htm)\n\n31.2\n[Certification of Rachel Vaknin, Chief Financial Officer](ex31-2.htm)\n\n32.1\n[Certification of Harel Gadot, Chairman, President and Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-1.htm)\n\n32.2\n[Certification of Rachel Vaknin, Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-2.htm)\n\n101.1\nInline\nXBRL Instance - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the\nInline XBRL document.\n\n101.SCH\nInline\nXBRL Taxonomy Extension Schema.\n\n101.CAL\nInline\nXBRL Taxonomy Extension Calculation.\n\n101.DEF\nInline\nXBRL Taxonomy Extension Definition.\n\n101.LAB\nInline\nXBRL Taxonomy Extension Labels.\n\n101.PRE\nInline\nXBRL Taxonomy Extension Presentation.\n\n104\nCover\nPage Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)\n\n** **\n\n28\n\n \n\n** **\n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned, thereunto duly authorized, this 13th day of May, 2026.\n\n \n\n** **\n**MICROBOT\nMEDICAL INC.**\n\n** **\n** **\n** **\n\n \nBy:\n\n*/s/\nHarel Gadot*\n\n \nName:\nHarel\nGadot\n\n \nTitle:\nChairman,\nPresident and Chief Executive Officer\n\n \n \n(Principal\nExecutive Officer)\n\n** **\n** **\n** **\n\n \nBy:\n\n*/s/\nRachel Vaknin*\n\n \nName:\nRachel\nVaknin\n\n \nTitle:\nChief\nFinancial Officer\n\n \n \n(Principal\nFinancial and Accounting Officer)\n\n** **\n\n29\n\n****** **"}